US veterans face high symptom burden, limited access to care in MPNs
US military veterans with myeloproliferative neoplasms (MPNs) endure a substantial symptom burden and limited access to care, indicating suboptimal management, according to the
Myeloproliferative Neoplasms
Cellular Therapy
Mantle Cell Lymphoma
FDA approves liso-cel for relapsed or refractory MCL
The US Food and Drug Administration (FDA) has approved Bristol Myers Squibb’s lisocabtagene maraleucel (liso-cel; Breyanzi) as a chimeric antigen receptor (CAR) T-cell
Multiple Myeloma
Belantamab Mafodotin Combination Improves PFS in Relapsed or Refractory Multiple Myeloma
A phase 3 trial has shown that the combination of belantamab mafodotin, bortezomib, and dexamethasone (BVd) had a significant benefit in terms of
Society Updates
Guillermo Garcia-Manero, MD | SOHO President 2024
The Board of Directors and the Steering committee of the Society of Hematologic Oncology are pleased to announce that Dr. Guillermo Garcia-Manero assumed the position of SOHO